Alexander, K. M., Cheng, R.-H., Grodin, J. L., Khouri, M. G., Wright, R. F., Maurer, M. S., … Gilmore, J. D. (2025). ACORAMIDIS IMPROVES NYHA CLASS AT MONTH 30 VERSUS PLACEBO IN PATIENTS WITH ATTR-CM: RESULTS FROM THE ATTRIBUTE-CM STUDY. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 85, pp. 1581–1581).

Alexander, Kevin Michael, Richard Kar-Hang Cheng, Justin Lee Grodin, Michel Georges Khouri, Richard F. Wright, Mathew S. Maurer, Daniel P. Judge, et al. “ACORAMIDIS IMPROVES NYHA CLASS AT MONTH 30 VERSUS PLACEBO IN PATIENTS WITH ATTR-CM: RESULTS FROM THE ATTRIBUTE-CM STUDY.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 85:1581–1581, 2025.

Alexander KM, Cheng RK-H, Grodin JL, Khouri MG, Wright RF, Maurer MS, et al. ACORAMIDIS IMPROVES NYHA CLASS AT MONTH 30 VERSUS PLACEBO IN PATIENTS WITH ATTR-CM: RESULTS FROM THE ATTRIBUTE-CM STUDY. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025. p. 1581–1581.

Alexander, Kevin Michael, et al. “ACORAMIDIS IMPROVES NYHA CLASS AT MONTH 30 VERSUS PLACEBO IN PATIENTS WITH ATTR-CM: RESULTS FROM THE ATTRIBUTE-CM STUDY.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 85, no. 12, 2025, pp. 1581–1581.

Alexander KM, Cheng RK-H, Grodin JL, Khouri MG, Wright RF, Maurer MS, Judge DP, Du J, Siddhanti S, Tamby JF, Katz L, Fox JC, Gilmore JD. ACORAMIDIS IMPROVES NYHA CLASS AT MONTH 30 VERSUS PLACEBO IN PATIENTS WITH ATTR-CM: RESULTS FROM THE ATTRIBUTE-CM STUDY. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025. p. 1581–1581.